Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Inovio Pharmaceuticals Inc (INO) vs Public Storage (PSA) Price & Performance

Inovio Pharmaceuticals IncTrade
Public StorageTrade

Price performance (Past 24H)

Key statistics

Inovio Pharmaceuticals Inc vs Public Storage — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $76.09M), while Public Storage trades at $324.41 (market cap $60.82B). The key difference: Public Storage is far larger — about 799.3× Inovio Pharmaceuticals Inc's market cap, and Public Storage pays a 3.68% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

INOPSA
Market Cap
$76.09M$60.82B
Sector
HealthReal Estate
52-Week High
$2.87$330.47
52-Week Low
$0.66$258.44
Enterprise Value
$47.10M$75.10B
Dividend Yield
3.68%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Inovio Pharmaceuticals Inc

No Aura AI signal available yet.

Public Storage

Public Storage (PSA) trades at $328.40, up 0.43% on the day, with a bullish technical signal from moving averages and a consensus price target of $333.88. The company reported Q2 2026 EPS of $2.55, beating estimates, and raised full-year guidance following the acquisition of National Storage Affiliates. Strong profitability is evident with a net income margin of 41.8% and ROE of 37.42%, though valuation multiples like P/E of 31.34 suggest a premium.

Outlook remains positive due to accretive acquisitions and dividend stability, with a $3.00 quarterly dividend declared. Risks include high valuation, interest rate sensitivity, and integration challenges from recent deals. Analyst sentiment is mixed with 28.6% buy ratings, but institutional activity shows both position increases and cuts, indicating cautious optimism.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO

About Public Storage

Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.

Read more on PSA